EADV 2019: Looking back at the Modern Face of Atopic Dermatitis

SANOFI-GENZYME & REGENERON-SPONSORED SYMPOSIUM ON:
Management of moderate-to-severe atopic dermatitis
in the era of targeted treatments

Click here to download the API

(▼) This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse reactions.

This email was sent to <<Email Address>>
why did I get this? unsubscribe from this list update subscription preferences
EADV · Via S. Balestra 22 B · Lugano 6900 · Switzerland